ICU Medical Stockholders Approve Key Proposals at Meeting

ICU Medical ( (ICUI) ) has provided an update.

On May 13, 2025, ICU Medical, Inc. held its annual meeting of stockholders, where several key proposals were approved. The stockholders approved an amendment to the 2011 Stock Incentive Plan, increasing the number of shares available for issuance and for incentive stock options by 2,150,000 shares each. Additionally, the election of directors, the ratification of Deloitte & Touche LLP as the independent auditor, the executive officer compensation, and a stockholder proposal for simple majority voting were all approved.

The most recent analyst rating on (ICUI) stock is a Hold with a $183.00 price target. To see the full list of analyst forecasts on ICU Medical stock, see the ICUI Stock Forecast page.

Spark’s Take on ICUI Stock

According to Spark, TipRanks’ AI Analyst, ICUI is a Neutral.

ICU Medical’s overall score reflects a company with solid revenue growth and cash flow but facing profitability challenges. The earnings call highlighted both strong financial actions and potential risks from tariffs and regulatory issues. Technical indicators suggest a cautious trading outlook, and valuation metrics raise concerns about potential overvaluation.

To see Spark’s full report on ICUI stock, click here.

More about ICU Medical

Average Trading Volume: 309,514

Technical Sentiment Signal: Sell

Current Market Cap: $3.55B

Learn more about ICUI stock on TipRanks’ Stock Analysis page.